CME Group (CME) Stock Price

CME Group Price

NASDAQ·CLOSED
267.79USD+0.57 (+0.21 %)
Market closed

Revenue has compounded at 9.9% per year over the past 19 years to 6.52 B USD. Earnings per share have grown at 8.6% per year over the last 19 years. CME Group's net margin stands at 62.0%, up from 56.2% several years earlier. CME Group currently offers a dividend yield of about 1.87%. The payout ratio is around 45% of earnings. The dividend has grown at 3.7% per year over the past 19 years. Analysts set a median price target of 308.04 USD, implying 15.0% above the current price. Of 20 analysts, 11 rate the stock a buy — an overall Buy consensus. The stock trades about 22% above its 52-week low.

CME Group stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of CME Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how CME Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing CME Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

CME Group Stock Price History
DateCME Group Price
7/31/2026267.79 USD
7/30/2026267.22 USD
7/29/2026263.65 USD
7/27/2026256.23 USD
7/23/2026254.32 USD
7/22/2026249.24 USD
7/21/2026237.38 USD
7/20/2026245.11 USD
7/17/2026245.05 USD
7/16/2026246.27 USD
7/15/2026245.18 USD
7/14/2026243.61 USD
7/13/2026242.65 USD
7/10/2026240.27 USD
7/9/2026239.71 USD
7/8/2026243.43 USD
7/7/2026240.75 USD
7/6/2026234.82 USD
7/2/2026236.60 USD
7/1/2026231.00 USD
6/30/2026220.83 USD
6/29/2026218.90 USD
6/26/2026221.00 USD
6/25/2026225.00 USD
6/24/2026231.68 USD
6/23/2026242.26 USD
6/22/2026245.91 USD
6/18/2026253.12 USD
6/17/2026252.53 USD
6/16/2026256.50 USD
6/15/2026268.03 USD
6/12/2026266.20 USD
6/11/2026266.61 USD
6/10/2026261.27 USD
6/9/2026255.94 USD
6/8/2026252.03 USD
6/5/2026256.15 USD
6/4/2026255.76 USD
6/3/2026252.49 USD
6/2/2026247.17 USD
6/1/2026267.74 USD
5/29/2026279.70 USD
5/28/2026278.29 USD
5/27/2026277.99 USD
5/26/2026282.03 USD
5/22/2026291.02 USD
5/21/2026291.51 USD
5/20/2026294.02 USD
5/19/2026302.37 USD
5/18/2026305.12 USD
5/15/2026298.86 USD
5/14/2026297.70 USD
5/13/2026297.13 USD
5/12/2026285.75 USD
5/11/2026282.58 USD
5/8/2026281.25 USD
5/7/2026286.85 USD
5/6/2026288.34 USD
5/5/2026286.82 USD
5/4/2026290.29 USD
5/1/2026289.54 USD
4/30/2026287.82 USD
4/29/2026287.27 USD
4/28/2026284.53 USD
4/27/2026281.94 USD
4/24/2026285.06 USD
4/23/2026285.47 USD
4/22/2026285.71 USD
4/21/2026284.40 USD
4/20/2026287.45 USD
4/17/2026287.65 USD
4/16/2026296.22 USD
4/15/2026296.90 USD
4/14/2026297.03 USD
4/13/2026300.59 USD
4/10/2026295.30 USD
4/9/2026298.93 USD
4/8/2026302.81 USD
4/7/2026310.58 USD
4/6/2026308.57 USD
4/5/2026308.57 USD
4/2/2026305.11 USD
4/1/2026305.11 USD
3/31/2026296.94 USD
3/30/2026295.35 USD
3/29/2026297.58 USD
3/27/2026293.78 USD
3/26/2026293.78 USD
3/25/2026297.58 USD
3/24/2026293.93 USD
3/23/2026302.68 USD
3/22/2026306.56 USD
3/20/2026307.32 USD
3/19/2026307.32 USD
3/18/2026310.71 USD
3/17/2026308.90 USD
3/16/2026313.33 USD
3/15/2026313.83 USD
3/13/2026311.40 USD
3/12/2026311.40 USD
3/11/2026311.19 USD
3/10/2026303.33 USD
3/9/2026306.34 USD
3/8/2026319.09 USD
3/6/2026317.10 USD
3/5/2026316.81 USD
3/4/2026320.00 USD
3/3/2026325.13 USD
3/2/2026326.46 USD
2/27/2026319.50 USD
2/26/2026316.45 USD
2/25/2026307.36 USD
2/24/2026319.03 USD
2/23/2026314.00 USD
2/20/2026308.09 USD
2/19/2026303.91 USD
2/18/2026302.55 USD
2/17/2026303.23 USD
2/13/2026303.07 USD
2/12/2026301.96 USD
2/11/2026302.48 USD
2/10/2026306.76 USD
2/9/2026307.24 USD
2/6/2026302.27 USD
2/5/2026297.38 USD
2/4/2026294.62 USD
2/3/2026293.07 USD
2/2/2026290.77 USD
1/30/2026289.06 USD
1/29/2026289.83 USD
1/28/2026286.05 USD
1/27/2026284.48 USD
1/26/2026284.05 USD
1/23/2026282.74 USD
1/22/2026281.41 USD
1/21/2026279.07 USD
1/20/2026281.72 USD
1/16/2026279.52 USD
1/15/2026272.59 USD
1/14/2026275.23 USD
1/13/2026268.45 USD
1/12/2026264.98 USD
1/9/2026262.45 USD
1/8/2026266.64 USD
1/7/2026266.85 USD
1/6/2026269.15 USD
1/5/2026275.06 USD
1/2/2026269.68 USD
12/31/2025273.08 USD
12/30/2025275.83 USD
12/29/2025278.42 USD
12/26/2025276.73 USD
12/24/2025276.38 USD
12/23/2025275.53 USD
12/22/2025273.20 USD
12/19/2025269.09 USD
12/18/2025265.79 USD
12/17/2025273.74 USD
12/16/2025272.95 USD
12/15/2025272.18 USD
12/12/2025273.55 USD
12/11/2025272.41 USD
12/10/2025266.33 USD
12/9/2025270.12 USD
12/8/2025272.07 USD
12/5/2025270.87 USD
12/4/2025273.19 USD
12/3/2025274.34 USD
12/2/2025277.49 USD
12/1/2025278.99 USD
11/28/2025281.46 USD
11/26/2025282.54 USD
11/25/2025276.98 USD
11/24/2025275.68 USD
11/21/2025273.09 USD
11/20/2025275.01 USD
11/19/2025272.49 USD
11/18/2025279.28 USD
11/17/2025279.13 USD
11/14/2025285.04 USD
11/13/2025283.54 USD
11/12/2025279.58 USD
11/11/2025278.43 USD
11/10/2025277.28 USD
11/7/2025276.50 USD
11/6/2025272.02 USD
11/5/2025267.87 USD
11/4/2025267.85 USD
11/3/2025263.82 USD
10/31/2025265.37 USD
10/30/2025267.62 USD
10/29/2025261.53 USD
10/28/2025266.33 USD
10/27/2025270.42 USD
10/24/2025269.27 USD
10/23/2025268.90 USD
10/22/2025267.81 USD
10/21/2025268.28 USD
10/20/2025267.62 USD
10/17/2025267.77 USD
10/16/2025264.02 USD
10/15/2025268.15 USD
10/14/2025267.18 USD
10/13/2025271.28 USD
10/10/2025271.47 USD
10/9/2025268.69 USD
10/8/2025264.94 USD
10/7/2025263.32 USD
10/6/2025262.05 USD
10/3/2025265.02 USD
10/2/2025265.62 USD
10/1/2025265.82 USD
9/30/2025270.19 USD
9/29/2025272.24 USD
9/28/2025272.24 USD
9/25/2025270.28 USD
9/24/2025268.73 USD
9/23/2025261.96 USD
9/22/2025261.17 USD
9/19/2025261.67 USD
9/18/2025260.59 USD
9/17/2025262.40 USD
9/16/2025259.83 USD
9/15/2025259.15 USD
9/12/2025261.72 USD
9/11/2025262.38 USD
9/10/2025259.91 USD
9/9/2025261.53 USD
9/8/2025262.58 USD
9/5/2025261.96 USD
9/4/2025267.43 USD
9/3/2025269.35 USD
9/2/2025265.40 USD
8/29/2025266.53 USD
8/28/2025266.77 USD
8/27/2025270.12 USD
8/26/2025271.61 USD
8/25/2025271.39 USD
8/22/2025269.54 USD
8/21/2025273.32 USD
8/20/2025274.61 USD
8/19/2025271.49 USD
8/18/2025270.41 USD
8/15/2025273.21 USD
8/14/2025274.70 USD
8/13/2025273.92 USD
8/12/2025275.88 USD
8/11/2025285.42 USD
8/8/2025283.02 USD
8/7/2025280.95 USD
8/6/2025281.35 USD
8/5/2025284.61 USD
8/4/2025287.10 USD
Access this data via the Eulerpool API

CME Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
5.58 B USD
3.60 B USD
3.23 B USD
Jan 1, 2024
6.13 B USD
4.70 B USD
3.53 B USD
Jan 1, 2025
6.52 B USD
5.45 B USD
4.04 B USD
Jan 1, 2026 (e)
7.03 B USD
6.31 B USD
4.42 B USD
Jan 1, 2027 (e)
7.38 B USD
6.63 B USD
4.66 B USD
Jan 1, 2028 (e)
7.86 B USD
7.05 B USD
5.00 B USD
Jan 1, 2029 (e)
8.46 B USD
7.59 B USD
5.41 B USD
Jan 1, 2030 (e)
8.73 B USD
7.83 B USD
5.79 B USD

CME Group Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 4, 2026, 12:12 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITB USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
3.333.603.644.314.874.884.695.025.586.136.527.037.387.868.468.73
6.888.091.3618.2512.970.31-3.977.0411.149.906.367.795.056.477.593.22
82.5384.9084.5284.4081.5382.4782.1585.0085.1686.1286.0986.0986.0986.0986.0986.09
2.753.053.083.643.974.033.854.274.755.285.616.056.366.777.287.52
1.991.151.521.421.062.892.813.653.604.705.456.316.637.057.597.83
59.7731.8841.6332.9521.7759.1459.9772.7864.4576.7083.5189.7489.7389.7389.7489.73
1.251.534.061.962.122.112.642.693.233.534.044.424.665.005.415.79
10.6523.02164.86-51.717.85-0.5225.232.0919.889.2714.729.255.487.278.147.05
4.908.906.144.555.505.906.858.509.6510.405.005.205.205.20
26.2981.63-31.01-25.9020.887.2716.1024.0913.537.77-51.924.00
338.25339.34340.49352.13358.35358.61359.02359.19359.69360.05360.23360.23360.23360.23360.23360.23
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales CME Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue CME Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare CME Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares CME Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against CME Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

CME Group stock margins

The CME Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CME Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CME Group.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
82.15 %
59.96 %
56.22 %
Jan 1, 2022
85.00 %
72.78 %
53.61 %
Jan 1, 2023
85.15 %
64.44 %
57.83 %
Jan 1, 2024
86.13 %
76.71 %
57.52 %
Jan 1, 2025
86.09 %
83.51 %
62.02 %
Jan 1, 2026 (e)
86.09 %
89.73 %
62.87 %
Jan 1, 2027 (e)
86.09 %
89.73 %
63.12 %
Jan 1, 2028 (e)
86.09 %
89.73 %
63.60 %

CME Group Stock Revenue, EBIT, Earnings per Share

The CME Group earnings per share therefore indicates how much revenue CME Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
13.06 USD
7.83 USD
7.34 USD
Jan 1, 2022
13.97 USD
10.17 USD
7.49 USD
Jan 1, 2023
15.51 USD
10.00 USD
8.97 USD
Jan 1, 2024
17.03 USD
13.06 USD
9.79 USD
Jan 1, 2025
18.10 USD
15.12 USD
11.23 USD
Jan 1, 2026 (e)
19.49 USD
17.51 USD
12.25 USD
Jan 1, 2027 (e)
20.47 USD
18.39 USD
12.92 USD
Jan 1, 2028 (e)
21.80 USD
19.58 USD
13.86 USD

CME Group business model & stock analysis

CME Group Inc, founded in 1898 as Chicago Butter and Egg Board, is an American exchange and trading platform for futures and options. It has become a global leader in derivatives trading volume. CME Group operates multiple exchange platforms specializing in various asset classes, with the most well-known being the Chicago Mercantile Exchange (CME) for financial futures and derivatives. The company's history dates back to the late 19th century when agricultural futures trading began in Chicago. It was formed by the merger of Chicago Mercantile Exchange Holdings Inc. and the Chicago Board of Trade in 2007, acquiring the New York Mercantile Exchange (NYMEX) and Kansas City Board of Trade (KCBT) in subsequent years. CME Group offers a wide range of futures and options contracts based on different asset classes, with a focus on currencies, interest rates, stock indexes, energy, and agriculture. The company operates internationally and has a strong presence in regulatory compliance. It provides clearing services to minimize counterparty risk in futures transactions. Notable products offered by CME Group include currency futures (Euro FX, Japanese Yen, Swiss Franc, British Pound Sterling), stock index futures (S&P 500, NASDAQ-100, Dow Jones Industrial Average), energy futures (oil, gas, electricity), agricultural futures (corn, soybeans, wheat), as well as newer offerings such as Bitcoin futures and Micro-E-mini Futures. CME Group's business model centers on providing a secure and transparent trading platform for hedging risks and generating capital returns. It earns revenue from fees charged for trading and clearing futures contracts. The company is highly regarded in the industry for its innovation and global market leadership.

CME Group SWOT Analysis

Strengths

CME Group Inc has a leading position in the global derivatives and options market, providing a diverse range of products and services.

The strong brand recognition and reputation of CME Group Inc help in attracting customers and maintaining market share.

The company benefits from advanced technology infrastructure, enabling efficient and reliable trading operations.

Weaknesses

CME Group Inc is highly dependent on market conditions, making it vulnerable to economic downturns and fluctuations in trading volumes.

The company faces intense competition from other exchanges, which may impact its market position and pricing power.

Limited diversification of its revenue streams makes CME Group Inc susceptible to risks associated with its core business.

Opportunities

Expansion into new geographical markets, particularly emerging economies, can provide growth opportunities for CME Group Inc.

The increasing demand for risk management tools and hedging instruments creates opportunities for the company to introduce innovative products.

Strategic partnerships and acquisitions can help CME Group Inc strengthen its market position and expand its product portfolio.

Threats

Regulatory changes and government policies can impact the operations and profitability of CME Group Inc.

The emergence of new technologies and competitors in the financial services industry poses a threat to the company's market share.

Fluctuations in interest rates and currency exchange rates can affect the financial performance of CME Group Inc.

CME Group Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

CME Group Employees
Details
Date
CME Group Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

CME Group Segments

CME Group Revenue by Segment

  • 3 Years

  • 5 Years

  • Max

Clearing and Transaction Fees
MarketData
OtherRevenue
Details
Date
Clearing and Transaction Fees
MarketData
OtherRevenue
Jan 1, 2018
3.67 B USD
449.60 M USD
192.80 M USD
Jan 1, 2019
3.95 B USD
518.50 M USD
403.40 M USD
Jan 1, 2020
3.90 B USD
545.40 M USD
440.80 M USD
Jan 1, 2021
3.77 B USD
576.90 M USD
347.70 M USD
Jan 1, 2023
4.59 B USD
663.70 M USD
326.70 M USD
Jan 1, 2025
5.28 B USD
803.10 M USD
436.40 M USD

CME Group Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

CME Group historical P/E ratio, EBIT multiple, and P/S ratio

CME Group annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

CME Group shares outstanding

The number of shares of CME Group was 360.23 M in 2025. This indicates how many shares CME Group is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
359.02 M Stocks
Jan 1, 2022
359.19 M Stocks
Jan 1, 2023
359.69 M Stocks
Jan 1, 2024
360.05 M Stocks
Jan 1, 2025
360.23 M Stocks
Jan 1, 2026 (e)
360.23 M Stocks
Jan 1, 2027 (e)
360.23 M Stocks
Jan 1, 2028 (e)
360.23 M Stocks

CME Group stock splits

In CME Group's history, there have been no stock splits.

CME Group Dividend History

24 years of dividend payments

YearAnnual DividendYoY ChangePayments
20262.60USDYTD
Mar 10, 20261.30USD 4.0%1/2
Jun 9, 20261.30USD 0.0%2/2
20255.00USD 51.9%
Mar 7, 20251.25USD 78.4%1/4
Jun 9, 20251.25USD 0.0%2/4
Sep 9, 20251.25USD 0.0%3/4
Dec 12, 20251.25USD 0.0%4/4
202410.40USD 7.8%
20239.65USD 13.5%
20228.50USD 24.1%
20216.85USD 16.1%
20205.90USD 7.3%
20195.50USD 20.9%
20184.55USD 25.9%
20176.14USD 31.0%

CME Group dividend history and estimates

In 2025, CME Group paid a dividend amounting to 5.00 USD. Dividend means that CME Group distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2021
6.85 USD
0.00 USD
3.25 USD
Jan 1, 2022
8.50 USD
0.00 USD
4.50 USD
Jan 1, 2023
9.65 USD
0.00 USD
5.25 USD
Jan 1, 2024
10.40 USD
0.00 USD
5.80 USD
Jan 1, 2025
5.00 USD
0.00 USD
0.00 USD
Jan 1, 2026 (e)
2.60 USD
2.60 USD
0.00 USD
Jan 1, 2027 (e)
0.00 USD
5.20 USD
0.00 USD
Jan 1, 2028 (e)
0.00 USD
5.20 USD
0.00 USD

CME Group dividend payout ratio

In 2025, CME Group had a payout ratio of 44.53%. The payout ratio indicates the percentage of the company's profits that CME Group distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
93.28 %
Jan 1, 2022
113.46 %
Jan 1, 2023
107.59 %
Jan 1, 2024
106.20 %
Jan 1, 2025
44.53 %
Jan 1, 2026 (e)
42.43 %
Jan 1, 2027 (e)
40.23 %
Jan 1, 2028 (e)
37.51 %

Current CME Group forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
1.51 %
Buy
55.00 % (11)
Hold
30.00 % (6)
Sell
15.00 % (3)
12M Price Target
308.04
Last Price
267.79
Currency
USD
12M Return Potential
15.03 %
LTM Return
0 %

CME Group Analyst Rating Actions

DateFirmActionRatingReliability
7/23/2026
Morgan Stanley
Morgan Stanley
MaintainedOverweight60
7/23/2026
JP Morgan
JP Morgan
MaintainedUnderweight80
7/23/2026
B of A Securities
B of A Securities
MaintainedUnderperform70
7/15/2026
Piper Sandler
Piper Sandler
MaintainedOverweight51
7/10/2026
Morgan Stanley
Morgan Stanley
MaintainedOverweight60
7/9/2026
Barclays
Barclays
MaintainedEqual Weight33
7/8/2026
TD Cowen
TD Cowen
MaintainedBuy60
7/6/2026
UBS
UBS
MaintainedNeutral51
7/2/2026
Raymond James
Raymond James
MaintainedOutperform74
6/22/2026
TD Cowen
TD Cowen
MaintainedBuy60

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

CME Group Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
7/22/20263.02USD-1.74 BUSD-2026 Q2
4/22/20263.20USD-1.82 BUSD-2026 Q1
2/4/20262.77USD-1.67 BUSD-2025 Q4
4/24/20242.39USD-1.47 BUSD-2024 Q1
2/6/20242.22USD-1.40 BUSD-2023 Q4
7/25/20232.09USD-1.30 BUSD-2023 Q2
4/25/20232.16USD-1.36 BUSD-2023 Q1
2/7/20231.95USD-1.25 BUSD-2022 Q4
10/26/20221.96USD-1.24 BUSD-2022 Q3
7/27/20221.95USD-1.26 BUSD-2022 Q2
...

EESG©

Eulerpool ESG Scorecard© for the CME Group stock

67/100
31
Environment
99
Social
70
Governance
E

Environment

20
Scope 1 - Direct Emissions309
Scope 2 - Indirect emissions from purchased energy10,448
Scope 3 - Indirect emissions within the value chain108,793
Total CO₂ emissions10,757
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees32
Percentage of women in management
Percentage of Asian employees25.1
Share of Asian management
Percentage of Hispanic/Latino employees6.4
Hispano/Latino Management share
Percentage of Black employees5.5
Black Management Share
Percentage of white employees60.9
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

CME Group shareholder structure

% Name
8.72109%
BLACKROCK, INC.
BLACKROCK, INC.
6.48011%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
4.45238%
STATE STREET CORP
STATE STREET CORP
3.38596%
JPMORGAN CHASE & CO
JPMORGAN CHASE & CO
2.60866%
MORGAN STANLEY
MORGAN STANLEY
2.53657%
GEODE CAPITAL MANAGEMENT, LLC
GEODE CAPITAL MANAGEMENT, LLC
...

CME Group Beneficial Ownership Filings (SEC 13D/G)

Free Float
98.6%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
13.70%
Marsico Capital Management, LLC             84-1434992
Marsico Capital Management, LLC             84-1434992
SEC ↗
11.00%
Sands Capital Management, LLC
Sands Capital Management, LLC
SEC ↗
10.00%
Capital World Investors **
Capital World Investors **
SEC ↗
9.30%
95-1411037
95-1411037
SEC ↗
8.72%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
7.45%
Vanguard Capital Management
Vanguard Capital Management
SEC ↗
6.70%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
6.13%
FMR LLC
FMR LLC
SEC ↗
6.13%
Edward C. Johnson 3d
Edward C. Johnson 3d
SEC ↗
4.60%
STATE STREET CORPORATION
STATE STREET CORPORATION
SEC ↗

CME Group Executives and Management Board

29 members · avg. age 59 · 31 % women

HD

Hon. Terrence Duffy (66)

Executive Chairman of the Board, Chief Executive Officer · since 1995

23.95 M USD

Management

LF

Ms. Lynne Fitzpatrick (45)

President, Chief Financial Officer

3.44 M USD
DS

Mr. Derek Sammann (56)

Senior Managing Director - Global Head of Commodities Markets

3.43 M USD
JW

Ms. Julie Winkler (50)

Chief Commercial Officer

3.42 M USD
SC

Mr. Sunil Cutinho (53)

Chief Information Officer

3.41 M USD
MD

Mr. Michael Dennis (44)

Senior Managing Director - Global Head, Fixed Income · since 2020

215,604.00 USD
SS

Ms. Suzanne Sprague (44)

Chief Operating Officer and Global Head of Clearing

Board of Directors

WS

Mr. William Shepard (78)

Independent Director · since 1997

342,770.00 USD
TB

Mr. Timothy Bitsberger (65)

Independent Director

325,687.00 USD
CC

Mr. Charles Carey (71)

Non-Executive Independent Vice Chairman of the Board · since 2007

322,187.00 USD
WH

Mr. William Hobert (61)

Independent Director

311,187.00 USD
PL

Ms. Phyllis Lockett (59)

Independent Director

309,437.00 USD
DK

Mr. Daniel Kaye (70)

Independent Director · since 2019

301,187.00 USD

CME Group Supply Chain

CME Group Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
17 companies
#NameTrend
1
Intercontinental Exchange
Supplier·Capital Markets·US
0.44
0.89
0.96
0.81
0.65
0.86
2
Nasdaq, Inc.
Supplier·Capital Markets·US
0.58
0.95
0.94
0.48
-0.01
0.75
3
Beeks Financial Cloud Grp
Supplier·Customer·IT Services·GB
0.29
0.90
-0.14
-0.15
0.20
0.72
4
News A
Supplier·Customer·Media·US
0.45
0.87
0.94
0.83
-0.03
0.71
5
S&P Global Inc.
Supplier·Capital Markets·US
-0.11
0.79
0.95
0.42
-0.03
0.60
#NameTrend
1
Japan Exchange Group, Inc.
Supplier
0.60
0.90
0.86
2
Trans-Lux
Supplier·Electronic Equipment, Instruments & Components·US
0.52
0.57
-0.37
-0.23
0.36
3
SEC Newgate S.p.A.
Supplier·N/A·IT
-0.30
-0.35
-0.73
-0.64
-0.53
4
-0.60
0.66
0.80
0.22
0.70
5
Singapore Exchange Limited
Supplier
-0.72
0.24
0.16
0.17
-0.67

Frequently asked questions about CME Group

The business model of CME Group Inc is centered around operating a global marketplace for derivatives, options, and futures contracts. As the world's largest futures exchange, CME Group facilitates trading across multiple asset classes, including agricultural products, energy, metals, interest rates, and equity indexes. It provides a platform for market participants to manage price risks, access liquidity, and enhance portfolio diversification. CME Group's business model relies on offering innovative trading products, robust risk management tools, and technologically advanced trading platforms to serve the needs of a diverse range of market participants, such as institutional investors, corporations, and individual traders.

CME Group Inc is primarily active in the financial industry.

CME Group Inc faces competition from various players in the market. Some of the main competitors include Intercontinental Exchange (ICE), Nasdaq, and Chicago Board Options Exchange (CBOE). These competitors also operate in the global derivatives exchange and clearing industry, offering similar products and services. However, CME Group Inc's leading position, diverse product range, and extensive market reach enable it to maintain a competitive edge in the industry.

CME Group Inc, founded in 1898 as Chicago Butter and Egg Board, has a rich history and a prominent position in the financial industry. Over the years, the company expanded its offerings and acquired several other exchanges, including the Chicago Mercantile Exchange and the New York Mercantile Exchange. Today, CME Group is the world's leading and most diverse derivatives marketplace, facilitating trading across various asset classes, including futures, options, and derivatives. With a strong focus on innovation and technology, CME Group continues to provide global customers with reliable and transparent markets, enabling them to manage risk and achieve their financial goals efficiently.

CME Group Inc, a renowned financial market corporation, has achieved significant milestones throughout its existence. The company has demonstrated remarkable growth and success, becoming the world's largest futures exchange operator. CME Group has expanded its offerings by introducing innovative products and technology, continually enhancing market efficiency and providing reliable risk management solutions to market participants. With its merger in 2007, CME Group created a global powerhouse, enabling seamless trading and clearing across multiple asset classes. CME Group's commitment to driving industry advancement has resulted in numerous accolades, solidifying its reputation as a leader in the global financial industry.

CME Group Inc is primarily present in various countries and regions worldwide. Its presence spans across the United States, with its headquarters in Chicago, Illinois. Additionally, CME Group has a significant presence in Europe, particularly in London and Belfast. The company also maintains offices and operations in Asia, specifically in Singapore and Tokyo. With its global reach, CME Group Inc serves as a leading financial exchange, connecting market participants from around the world and offering a diverse range of derivatives and futures products.

CME Group Inc represents a steadfast commitment to integrity, innovation, and collaboration. Known as the leading derivatives marketplace, CME Group fosters a transparent and trusted environment for global financial markets. With a focus on providing reliable risk management solutions, CME Group empowers market participants to manage their portfolios efficiently. The company's philosophy revolves around driving market efficiency while ensuring fairness and equal access to all participants. CME Group's dedication to customer-centric solutions, technological advancements, and industry-leading expertise solidifies its position as a trusted partner in the ever-evolving financial landscape.

Analysts currently set an average price target of 297.93 USD for the CME Group stock (median: 308.04 USD), implying +11.3 % versus the latest price. The consensus is based on 20 analyst ratings.

20 analysts currently rate the CME Group stock: 11 recommend buying, 6 holding and 3 selling. For 2026, analysts expect CME Group to generate revenue of 7.03 B USD and earnings per share of 12.27 USD.

Converted at the current exchange rate, the CME Group share trades at 232.63 EUR (267.79 USD).

The CME Group share (CME) is listed on 9 stock exchanges, including: NASDAQ (CME), XETRA (MX4A.DE), Frankfurt (MX4A.F), München (MX4A.MU), Düsseldorf (MX4A.DU), London (0HR2.L), London (0HR2.L), SIX (Zürich) (MX4A.SW).

The CME Group Inc is one of the world's leading companies in the derivatives exchange sector. Its business model is based on trading futures and options on commodities, stock indices, interest rates, and currencies on the exchanges of Chicago and New York. The CME Group offers a wide range of financial products that enable its customers to hedge risks or speculate on the price movements of assets. The products offered include futures contracts, options contracts, swap contracts, and other complex derivative instruments. The CME Group is divided into four business segments: first, there is the agricultural commodities segment, where futures on corn, wheat, soybeans, and other agricultural products are traded, for example. The energy segment includes futures and options on natural gas, oil, and electricity. The metals and minerals segment offers futures and options on gold, silver, copper, and other precious metals. Finally, there is the interest rates and currencies segment, where futures and options on various currencies and interest rates are traded. In addition to offering financial products, the CME Group also provides various services, such as data and information services and clearing services. In this context, it also operates clearing houses that settle transactions between customers, clear them in real-time, and thereby minimize risk for all parties involved. To serve its customers in the best possible way, the CME Group has also developed several platforms. The Global Command Center (GCC) is one of the most advanced trading platforms in the world and offers an optimal data- and information-based trading environment while also providing complex analysis functions to its customers. In recent years, the CME Group has become a leading provider in the derivatives exchange sector. Its innovative technology and efficient transaction processing, as well as the high quality of its products and services, have contributed to an increase in trading volumes. Today, leading financial institutions, hedge funds, companies, and individual investors trade at the CME Group, which repeatedly sets standards through its market-dominating position.

The expected revenue of CME Group is 7.03 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of CME Group is 4.42 B USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of CME Group is currently 21.83. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the CME Group stock.

The price-to-sales ratio (P/S) of CME Group is currently 13.72. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the CME Group stock.

The Eulerpool Quality Score for CME Group is 7/10.

The ISIN of CME Group is US12572Q1058. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of CME Group is A0MW32. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of CME Group is CME. The ticker symbol is used to trade CME Group shares on the stock exchange.

Over the past 12 months, CME Group paid a dividend of 5.00 USD . This corresponds to a dividend yield of about 1.87 %. For the coming 12 months, CME Group is expected to pay a dividend of 5.20 USD.

The current dividend yield of CME Group is 1.87 %.

CME Group pays a dividend, distributed in the months of , , , .

CME Group paid dividends every year for the past 23 years.

For the upcoming 12 months, dividends amounting to 5.20 USD are expected. This corresponds to a dividend yield of 1.94 %.

CME Group is assigned to the 'Finance' sector.

To receive the latest dividend of CME Group from amounting to 1.3 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, CME Group distributed 10.4 USD as dividends.

The dividends of CME Group are distributed in USD.

All fundamentals and in-depth analysis of CME Group

Our stock analysis for CME Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CME Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.